abstract |
The present invention relates to a RNAi agent targeting TMPRSS6 gene, such as a double-stranded RNAi agent, and a method for inhibiting the expression of TMPRSS6 using such RNAi agents, and treating a condition associated with TMPRSS6, such as an iron overload-related disorder, such as β-Mediterranean Method of the subject of anemia or hemochromatosis. |